Documents A to Z

| 1 | 2 | 3 | 4 | 5 | 7 | 8 | 9 | A | B | C | D | E | F | G | H | I | J | L | M | N | O | P | Q | R | S | T | U | V | W | Z

M

10th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines PDF

M

11th Invitation for Expression of Interest (EOI) for antimalarial medicines published

M

16th Annual WHO PQT Medicines Quality Assessment Training (virtual), 10-13 June 2024 - Agenda PDF

M

16th Annual WHO PQT Medicines Quality Assessment Training (virtual), 10-13 June 2024 - Agenda PDF

M

17th Annual PQT Medicines Quality Assessment Training, 9 – 12 June 2025 - Agenda PDF

M

1st Invitation to Manufacturers of Biotherapeutic Products (BTPs) and Similar Biotherapeutic Products (SBPs)to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Team - Biotherapeutic Products (BTPs) PDF

M

1st Invitation to manufacturers of medicinal products for treatment of Apnoea in Preterm infants to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF

M

1st Invitation to manufacturers of medicinal products for treatment of bacterial infections in children to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF

M

1st Invitation to manufacturers of medicinal products for treatment of disorders caused by use of tobacco, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF

M

1st Invitation to manufacturers of medicinal products for treatment of infections in newborn and young infants and childhood pneumonia, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF

M

1st Invitation to manufacturers of medicinal products for treatment of multi-drug resistant bacterial infections, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit PDF

Recently Updated Documents

PQS Application Review Template for E008 AD syringe V1.0 21JUL2025

PQS Application Review Template for E013 RUP syringe V1.0 21JUL2025

Notes on the design of bioequivalence study: cabotegravir + rilpivirine

Notes on the design of bioequivalence study: lamivudine / dolutegravir

ePQS - External Guidance - FPP Post-prequalifiation Change Application

WHO Technical Report Series Location

WHO Technical Report Series documents relating to development, production, distribution, inspection and quality control of medicines can be found in the guidelines section of the WHO web pages dealing with quality assurance of medicines. The guidelines most relevant to WHO medicines prequalification are listed and accessible on the WHO Technical Report Series page.